Protocols/Evolve
Weight Loss

EvolveTirzepatide

Dual-action GLP-1/GIP. The next generation of weight management.

$249/month
HSA/FSA eligible Ships free Cancel anytime
Tirzepatide

About

What it is

Tirzepatide is a dual GIP and GLP-1 receptor agonist — the first in its class. It targets two incretin pathways simultaneously, which clinical trials have shown leads to even greater weight loss than single-agonist GLP-1s. Average body weight reduction of 20-22% in trials.

How it works

Tirzepatide is the first dual GIP and GLP-1 receptor agonist. By activating both incretin pathways, it produces stronger appetite suppression and greater metabolic improvement than GLP-1-only drugs. GIP activation enhances fat metabolism and energy expenditure, while GLP-1 reduces appetite and improves insulin sensitivity — a synergistic mechanism that clinical trials show outperforms single-agonist approaches.

Benefits

Clinically proven 20-22% average weight reduction
Dual GIP/GLP-1 mechanism for enhanced efficacy
Superior appetite suppression and metabolic improvement
Meaningful improvement in cardiovascular risk factors

Who it's for

Maximum weight loss efficacy
Those who want the most advanced option
Metabolic syndrome support
Long-term body composition goals

What to expect

Week 1–2

Starting dose. Appetite begins to shift. Mild GI symptoms possible as the body adjusts.

Week 3–4

Dose increases. Appetite suppression strengthens. Food noise quiets significantly.

Week 6–8

Visible weight loss. Dual GIP/GLP-1 mechanism drives enhanced fat metabolism.

Week 12–16

Substantial body composition changes. Blood sugar and metabolic markers improve.

Week 24+

Clinical trials show 20-22% average body weight reduction. Continued improvement through week 72.

Safety & tolerability

Tirzepatide has been through rigorous Phase 3 clinical trials (SURMOUNT 1-4) and is FDA-approved for both diabetes and weight management. Its side-effect profile is comparable to other GLP-1s — primarily transient GI symptoms during dose titration. Our care team uses a gradual titration protocol to minimize discomfort. Every batch is compounded from pharmaceutical-grade, single-source API and independently tested for purity, potency, and sterility.

How we compound

Single-source API

Every peptide is sourced from one vetted pharmaceutical-grade supplier — no blending from multiple sources.

Third-party tested

Independent labs verify purity, potency, sterility, and endotoxin levels before any batch is released.

Care team reviewed

A real person reviews your profile, your protocol, and your progress. Not an algorithm.

Share this protocol

$249/mo